Botox Hh Training

8/2/2019 Botox Hh Training

1/15

BOTOX InjectorTraining

Now you can help!

November 2004

Marks owned by Allergan, Inc.

2004 Allergan, Inc., Irvine, CA 92612


2/15

Overview of Injector Training

Patient preparation

Supplies needed

Iodine starch test

BOTOX reconstitution

BOTOX injection

Please see important safety information on slide 12.


3/15

Patient Preparation

Shave underarms

Abstain from use of over-the-counter

deodorants or antiperspirants for 24 hoursprior to treatment

Rest comfortably without exercise, hotbeverages, etc., for approximately

30 minutes prior to treatment

Please see Important Safety Information on slide 12.


4/15

Supplies Needed

Reconstitution

0.9% nonpreserved

sterile saline only BOTOX 100 units

20-gauge, 1-inchextraction needle

Iodine Starch Test

Iodine solution

Starch Powder

Surgical pen

Alcohol (to cleanarea)

Injection

30-gauge, -inch

injection needle



5/15

Perform the Iodine Starch Test

Dry affected axilla

Paint area with iodine swab

Be sure to cover excessarea around axilla

Let dry

Brush area with starchpowder

Wait 10 minutes



6/15


Blue-black mark willidentify affected area

Circle affected area with

surgical marker, thenclean area inside circle withalcohol



7/15


Use a surgical pen andstandard ruler to mark injectionpoints:

1 to 2 cm apart

Staggered to allow for ringeffect of intradermalinjections

Count injection points andallocate recommended dosageof BOTOX solution perinjection, based on:

50 Units per axilla



8/15

BOTOX Reconstitution

Be certain youve received actual BOTOXproduct from Allergan

Look for holographic film on vial; Allerganshould appear within rainbow lines

If you do not see rainbow lines or Allergandoes not appear, do not use product and

please contact Allergan, Inc., directly at(800) 890-4345 from 8:00 a.m. to 4:00 p.m.Pacific time.



9/15

BOTOX Reconstitution

Using a 21-gauge, 1 - inch length needle, draw up 4 mL of 0.9%nonpreserved sterile saline into syringe

Insert needle at a 45angle and slowly inject saline into BOTOX

vial Ensure vacuum is present in vial, which means sterility of vial is intact

Do not use vial if there is no vacuum present

Release vacuum by disconnecting syringe from reconstitutionneedle (with needle remaining attached to bottle) and allowing air toflow into vial and neutralize pressure

Gently mix BOTOX

with saline by rotating vial; do notinvert vial

Attach a new sterile syringe to remaining needle and draw fluid frombottom corner of vial for full extraction; do not invert vial

Remove reconstitution needle from syringe and attach a 30-gaugeinjection needle, which is recommended needle for axillary injections

BOTOX

Must Be Properly ReconstitutedWith Only 0.9% Nonpreserved SalineSolution Prior to Injecting



10/15

BOTOX Injection

Inject at a 45 angle to skinsurface

Bevel side up to minimizeleakage and ensure injections

remain intradermal A depth of approximately

2 mm

Be sure not to inject directly

on ink mark to avoida permanent tattoo effect



11/15

BOTOX Injection

Clean treated area withalcohol

Treatment complete



12/15

Important Safety Information

BOTOX treatment is contraindicated in the presence of infection at the proposedinjection site(s) and in individuals with known hypersensitivity to any ingredient in theformulation. Serious and/or immediate hypersensitivity reactions have been rarelyreported. These reactions include anaphylaxis, urticaria, soft tissue edema, anddyspnea. If such a reaction occurs, further BOTOX injection should be discontinuedand appropriate medical therapy immediately instituted. BOTOX should only bediluted with 0.9% nonpreserved sodium chloride. Other diluents, including lidocaine,should not be used for reconstitution. Individuals with peripheral motor neuropathicdiseases (eg, amyotrophic lateral sclerosis or motor neuropathy) or neuromuscularjunctional disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should onlyreceive BOTOX treatment with caution. Individuals with neuromuscular disordersmay be at increased risk of clinically significant systemic effects including severedysphagia and respiratory compromise from typical doses of BOTOX. The mostfrequently reported adverse events (3%-10% of patients) were injection-site pain andhemorrhage, non-axillary sweating, infection, pharyngitis, flu syndrome, headache,fever, neck or back pain, pruritus, and anxiety.

Please see accompanying full prescribing information or visit www.botox.com.
http://www.botox.com/http://www.botox.com/


13/15

Back Up


14/15

Hyperhidrosis Disease Severity

Scale (HDSS) HDSS is a 4-point scale designed to assess severity

of hyperhidrosis in everyday clinical practice or inclinical research and effectiveness of hyperhidrosis

treatment HDSS can be administered by an interviewer or self-

completed by patient

HDSS assesses disease severity based on extent of

excessive-sweating-related impairment of dailyactivities



15/15

Hyperhidrosis

DiseaseSeverity Scale


Documents

Botox Hh Training